Stay ahead of the curve on the Medicaid Drug Rebate Program’s Final Rule, which takes effect on November 19, 2024, using our comprehensive white paper packed with valuable insights on what provisions could impact different...
The wave of FDA-approved cell and gene therapies (CGT) is transforming treatment options for diseases that once had few solutions. As more CGTs move from clinical trial to commercial approval and availability, navigating the complexities...
Cell and gene therapy (CGT) is emerging as one of the most dynamic and innovative fields in the pharmaceutical industry. The journey began in 2017 with the groundbreaking approval of Kymriah (tisagenlecleucel), a CAR-T cell...
